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Abstract
Vaccination of the elderly is an important factor in limiting the impact of influenza in the com-
munity. The aim of this study was to investigate the factors associated with influenza vacci-
nation coverage in hospitalized patients aged65 years hospitalized due to causes
unrelated to influenza in Spain. We carried out a cross-sectional study. Bivariate analysis
was performed comparing vaccinated and unvaccinated patients, taking in to account
sociodemographic variables and medical risk conditions. Multivariate analysis was per-
formed using multilevel regression models. We included 1038 patients: 602 (58%) had
received the influenza vaccine in the 2013–14 season. Three or more general practitioner
visits (OR = 1.61; 95% CI 1.19–2.18); influenza vaccination in any of the 3 previous seasons
(OR = 13.57; 95% CI 9.45–19.48); and 23-valent pneumococcal polysaccharide vaccination
(OR = 1.97; 95% CI 1.38–2.80) were associated with receiving the influenza vaccine. Vacci-
nation coverage of hospitalized elderly people is low in Spain and some predisposing char-
acteristics influence vaccination coverage. Healthcare workers should take these
characteristics into account and be encouraged to proactively propose influenza vaccina-
tion to all patients aged65 years.
Introduction
During seasonal epidemics, large numbers of influenza infections may occur in all age groups.
In most persons, influenza is a self-limiting illness, but serious secondary complications
develop in some infected persons. Influenza affects global health and economies and the
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resulting illnesses often require hospitalization, overwhelming hospital and other health care
systems and resulting in excess influenza-related deaths [1].
In elderly people, influenza causes complications of other underlying diseases. Increases in
the annual estimated number of deaths resulting from influenza since the 1970s have been
attributed to the disproportionate growth of the population aged65 years, who account for
90% of deaths caused by influenza [2].
The capacity of influenza A and B viruses to undergo gradual antigenic change in their sur-
face antigens is taken into account in seasonal influenza vaccination. The annual administra-
tion of seasonal influenza vaccine, especially in persons known to be at high risk of serious
complications as a result of influenza infection, is the focus of current efforts to reduce the dis-
ease impact [1,2].
Observational studies in different communities have shown that annual influenza vaccina-
tion reduces hospitalizations and all-cause deaths in the elderly [3–6]. The World Health Orga-
nization strategy and action plan for healthy ageing in Europe, 2012–2020 considered the
vaccination of older people in order to reduce the health risks (morbidity and mortality) as a
priority intervention [7].
A systematic review of studies on the social determinants of seasonal influenza vaccination
in adults aged65 years suggests that the probability of receiving the vaccine is influenced by
structural and healthcare-related social determinants [8].
In Spain, 17.6% of the population was aged65 years in 2013 [9] and this is forecast to
increase to 30.8% in 2050 [10]. The proportion of institutionalized persons in this age group is
3.6% [11].
The aim of this study was to investigate the factors associated with influenza vaccination
coverage in people aged65 years hospitalized due to causes unrelated to influenza in Spain.
Materials and Methods
Study design
We carried out a cross-sectional study in hospitalized patients aged65 years from 19 hospi-
tals located in the main cities of seven Spanish regions (Andalusia, Basque Country, Catalonia,
Castile and Leon, Madrid, Navarra and Valencia Community) with unplanned hospital admis-
sion (patients not admitted for scheduled surgery or other treatments) due to causes other than
acute respiratory disease, pneumonia or influenza-like illness were recruited between Novem-
ber 2013 and May 2014.
Selection of patients
Patients included in the study were sought from patients admitted to the internal medicine ser-
vice through the emergency department, and from patients admitted to the general surgery,
otorhinolaryngology, ophthalmology, dermatology and traumatology services. Patients who
did not give written consent were excluded, as were residents of nursing homes. In Spain, influ-
enza vaccination is offered on site to all residents of nursing homes, in whom vaccine coverages
are close to 100%, while suboptimal coverages are concentrated in non-institutionalized sub-
jects who must attend to a health care centre to be vaccinated.
Dependent and independent variables
The dependent variable was influenza vaccination in the 2013–2014 season. Patients were con-
sidered vaccinated with the seasonal influenza vaccine if they had received a dose of the vaccine
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during the 2013–2014 season. Information on the vaccination status was obtained from vacci-
nation registers, hospital medical records, vaccination cards or primary healthcare records.
Specifically-trained health professionals used a structured questionnaire to collect informa-
tion on independent variables by patient interview and review of medical records. Independent
variables were grouped in three categories according to the socio-behavioural model proposed
by other authors [12–14], predisposing characteristics, enabling resources and risk medical
conditions. The following predisposing characteristics were recorded: age, sex, educational
level, smoking, alcohol intake, vaccination status against pneumococcal disease and influenza
vaccination history in the three previous influenza seasons. Variables related to social support
were collected to measure enabling resources: marital status, number of general practitioner
(GP) visits during the last year, number of hospital visits during the last year, whether the
patient lived alone or at home with cohabitants, and the Barthel index, which has a total score
ranging from 0 (complete dependence) to 100 (complete independence), as a measurement of
limitations in activity in the patients included in the study. Risk medical conditions included
were those frequently associated with recommendations on influenza vaccination [1,2]:
chronic obstructive pulmonary disease, chronic respiratory failure, history of pneumonia dur-
ing the last two years, neoplasia, transplantation, immunosuppressive treatment, asplenia, dia-
betes, renal failure, nephrotic syndrome, autoimmune disease, AIDS, asymptomatic HIV
infection, congestive heart disease, disabling neurological disease, obesity, chronic liver disease,
hemoglobinopathy or anaemia, cognitive dysfunction, convulsions and neuromuscular disease.
Statistical analysis
A bivariate analysis was made to compare vaccinated and unvaccinated patients taking into
account the sociodemographic variables and risk medical conditions. As each Spanish region
may introduce specific vaccination programs for specific population groups and because
regions have some degree of autonomy in organizing health services, persons living in the same
region tend to have similar access to health care. Therefore, to estimate the crude and adjusted
odds ratio (OR), we used multilevel regression models that consider the outcome variable
among people from the same region, in order to obtain accurate statistical estimates of vaccina-
tion predictors [15]. Covariates were introduced into the model using a backward stepwise pro-
cedure, with a cut-off point of p<0.2.
Model 1 included only variables related to enabling resources; model 2 also included predis-
posing variables and model 3 included enabling resources, predisposing variables and risk
medical conditions.
The analysis was performed using the SPSS v.18 statistical package and the R v3.1.2 statisti-
cal software (http://cran.r-project.org).
Ethical considerations
All data collected were treated as confidential, in strict observance of legislation on observa-
tional studies. The study was approved by the Ethics Committees of the hospitals involved
(Comité Ético de Investigación Clínica del Hospital Clínic de Barcelona; Comité Ético de
Investigación Clínica del Hospital Universitari Mutua de Terrassa; Comité Ético de Investiga-
ción Clínica de la Corporació Sanitaria Parc Taulí de Sabadell; Comité Ético de Investigación
Clínica del Hospital de Mataró, Consorci Sanitari del Maresme; Comité Ètic d’Investigació
Clínica de la Fundació Unio Catalana Hospitals; Comité Ético de Investigación Clínica Área de
Euskadi; Comité Ético de Investigación Clínica Área de Salud de Burgos y Soria; Comité Ético
de Investigación Clínica Área de Salud de León; Comité Ético de Investigación Clínica Área de
Salud Valladolid– Este; Comité Coordinador de Ética de la Investigación Biomédica de
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Andalucía; Comité Ético de Investigación Clínica del Hospital Ramón y Cajal, Madrid and
Comité Ético de Investigación Clínica del Consorcio Hospital General Universitario de Valen-
cia). Written informed consent was obtained from all patients included in the study.
Results
Of the 1038 patients included in the study, 602 (58%) had received the influenza vaccine in the
2013–2014 season.
The distribution of the study variables (predisposing characteristics, enabling resources and
medical risk conditions) in vaccinated and unvaccinated patients is shown in Table 1. Accord-
ing to age, patients aged90 years had the highest vaccination coverage (64%), followed by the
85–89 years age group (63.7%), and the lowest coverage was observed in the 65–69 years age
group (44.2%). A history of influenza vaccination in any of the three previous seasons was
found in 78.3% of persons vaccinated during the 2013–14 season compared with only 21.7% in
unvaccinated patients. Single patients had lower vaccination rates than patients with partners
(41.9% and 61.3%, respectively). Patients who made3 GP visits in the previous year had
higher vaccination rates than those who did not (62.2% and 37.8%, respectively). Patients living
at home in cohabitation had higher rates (60.0%) than those living alone (49.2%).
No differences were observed in vaccinated and unvaccinated patients with respect to edu-
cational level, sex, level of dependency or the presence of risk medical conditions. S1 Table
shows the distribution of risk medical conditions in vaccinated and unvaccinated patients.
The results of the multilevel regression model are shown in Table 2. Variables related to
enabling resources (Model 1) significantly associated with vaccine uptake were being single
(OR = 0.55; 95% CI 0.32–0.93),3 GP visits in the previous year (OR = 1.72; 95% CI 1.31–
2.26) and a Barthel index<40 (OR = 0.65; 95% CI 0.44–0.97).
Predisposing characteristics (Model 2) associated with influenza vaccination in the 2013–14
season were influenza vaccination in any of the 3 previous seasons (OR = 13.07; 95% CI 9.14–
18.67) and 23-valent pneumococcal polysaccharide vaccination (OR = 1.95; 95% CI 1.37–2.78).
Single status and3 GP visits were also associated with influenza vaccination.
After the inclusion of risk medical conditions (Model 3), the variables associated were the
same as in model 2, with only very-slight increases in the values of the OR for3 GP visits
(OR = 1.61; 95% CI 1.19–2.18); for influenza vaccination in any of the 3 previous seasons
(OR = 13.57; 95% CI 9.45–19.48); and for previous vaccination with the 23-valent pneumococ-
cal polysaccharide vaccine (OR = 1.97; 95% CI 1.38–2.80).
Discussion
The results of this study show that influenza vaccination coverage in elderly hospitalized
patients in Spain (58.0%) is clearly lower than the 75% target proposed by the World Health
Assembly for people aged65 years [16]. A Council’s recommendation of the Commission of
the European Community states that concerted action at the community level should be taken
to contain seasonal influenza by encouraging vaccination among at-risk groups, with the pur-
pose of reaching the target of 75% vaccination coverage of the older age groups recommended
by the WHO, as far as possible by 2015 [17]. This target was not reached, with the median
being 44.7% and only two member states achieving the target in the 2012–13 season: the Neth-
erlands and the United Kingdom [18].
The coverage obtained in this study is very close to that of other Spanish and international
studies. In women in the same age group in Galicia, vaccination coverage between 2000 and
2004 was 56.8% [19]. In a more recent study in Navarra [20], the coverage in non-institutional-
ised persons aged65 years in the 2010–11 season was 58.6% and, similar to the results of the
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Table 1. Distribution of vaccinated and non-vaccinated patients according to sociodemographic characteristics, clinical conditions and history of
vaccination.
Vaccinated patients n (%),
N = 602
Unvaccinated patients n (%),
N = 436
Crude OR p
value
Predisposing characteristics
Age group
65–69 69 (44.2%) 87 (55.8%) 1
70–74 112 (57.1%) 84 (42.9%) 1.69 (1.10–2.59) 0.02
75–79 144 (58.1%) 104 (41.9%) 1.71 (1.14–2.56) 0.01
80–84 166 (62.9%) 98 (37.1%) 2.11 (1.41–3.16) <0.001
85–89 79 (63.7%) 45 (36.3%) 2.08 (1.27–3.42) 0.003
90 32 (64.0%) 18 (36.0%) 2.08 (1.06–4.08) 0.03
Sex
Male 337 (60.4%) 221 (39.6%) 1
Female 265 (55.2%) 215 (44.8%) 0.78 (0.61–1.00) 0.05
Education level
No/primary education 470 (58.2%) 337 (41.8%) 1
Secondary or higher 127 (56.2%) 99 (43.8%) 0.84 (0.61–1.16) 0.29
Smoking status
Non smoker 336 (59.1%) 233 (40.9%) 1
Ex-smoker 224 (57.4%) 166 (42.6%) 0.98 (0.75–1.28) 0.87
Smoker 40 (51.9%) 37 (48.1%) 0.79 (0.48–1.28) 0.33
Alcohol intake
No 582 (58.3%) 417 (41.7%) 1
Yes 17 (51.5%) 16 (48.5%) 0.74 (0.37–1.49) 0.40
23-valent pneumococcal polysaccharide
vaccine
No 274 (44.0%) 349 (56.0%) 1
Yes 328 (79.0%) 87 (21.0%) 6.18 (4.39–8.69) <0.001
Inﬂuenza vaccine in any of the 3 previous
seasons
No 62 (17.8%) 286 (82.2%) 1
Yes 540 (78.3%) 150 (21.7%) 16.76 (12.03–
23.34)
<0.001
Enabling resources
Marital status
Married/Cohabiting 356 (61.3%) 225 (38.7%) 1
Single 36 (41.9%) 50 (58.1%) 0.42 (0.26–0.67) 0.001
Widowed 195 (57.4%) 145 (42.6%) 0.85 (0.65–1.12) 0.26
Separated/Divorced 12 (46.2%) 14 (53.8%) 0.57 (0.26–1.26) 0.16
No. of GP visits
0–2 160 (48.5%) 170 (51.5%) 1
3 435 (62.2%) 264 (37.8%) 1.72 (1.31–2.25) <0.001
No. of hospital visits
0–2 358 (56.5%) 276 (43.5%) 1
3 236 (60.1%) 157 (39.9%) 1.17 (0.90–1.51) 0.24
Household size
Live alone 97 (49.2%) 100 (50.8%) 1
Lives with cohabitant 503 (60.0%) 336 (40.0%) 1.52 (1.11–2.08) 0.01
Barthel index
(Continued)
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present study, the highest coverage was in the 85–89 years age group. In Israel [21], the cover-
age in persons aged65 years in 2008–09 was 59.2%, and an increase was also observed in
older age groups.
Other authors have found higher coverages. In the United States in the 2013–14 influenza
season, the coverage was 64.7% in persons aged65 years [22]. The coverage was 73% in
2010–11 in patients aged>65 years seen by general practitioners included in the computerized
disease-surveillance system in France [23]. In many European countries, the vaccine coverage
in people aged>65 years is even lower than was found in our study [18,24].
In all the models in the present study, single marital status was associated with a lower cov-
erage and3 GP visits in the previous year with a higher coverage. Single marital status was
also associated with a lower coverage in an Italian study [14]. In an Irish study [25] widowed
persons had a lower coverage than married ones, but the Spanish study [19] found that older
married women had a significantly-higher probability of being vaccinated.
The association between vaccination coverage and the number of GP visits is in agreement
with other studies in Spain and other countries. [19,20,25–30]
Like most studies [14,22,25,27,30,31], no association was found between sex and influenza
vaccination coverage. However, studies in Spain and Israel have found higher coverages in
males [20,21,26]. We found no association between vaccination coverage and educational level,
in agreement with other authors [19,21,25,27,32].
An association between a higher Barthel index and vaccination coverage was found in
model 1, but was not exhibited in models 2 and 3. There is contradictory evidence on the rela-
tionship between influenza vaccination and the level of dependence. A Hong Kong study by
Lau et al [31] found that participants with a higher Barthel index were more likely to be vacci-
nated, but in the final multivariable logistic model no association was found. In contrast, a
study in Navarra found that a high level of dependence was associated with vaccination [20].
In models 2 and 3, we found a very close association between influenza vaccination in any of
the three previous seasons and influenza vaccination in 2013–14, in agreement with other studies
in Europe [20,23,27], Canada [29] and China [31]. Likewise, a history of pneumococcal vaccina-
tion was associated with influenza vaccination. A US study [33] found that 95% of persons vacci-
nated against influenza had received the pneumococcal vaccine. In our study, the figure was
54.5%, but in models 2 and 3 this variable was associated with influenza vaccination. Two studies
in Canada [29,30] found that participants reporting having received influenza vaccination at
least once were significantly more likely to report having received the pneumococcal vaccine.
We found no association between risk medical conditions and vaccination coverage, similar
to the results of a Brazilian study [32]. Lau et al [31] found that patients with more risk medical
conditions were less likely to be vaccinated, but other authors have found contrary results
[14,20,23].
Table 1. (Continued)
Vaccinated patients n (%),
N = 602
Unvaccinated patients n (%),
N = 436
Crude OR p
value
40 537 (58.9%) 374 (41.1%) 1
< 40 63 (50.4%) 62 (49.6%) 0.73 (0.50–1.07) 0.11
Risk medical conditions
No 69 (59.5%) 47 (40.5%) 1
Yes 533 (57.8%) 389 (42.2%) 0.95 (0.64–1.41) 0.80
OR: odds ratio, GP: general practitioner
doi:10.1371/journal.pone.0147931.t001
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The role of primary care physicians in promoting vaccination in the elderly has been
widely recognized [23,34,35]. In a recent Spanish study [36], influenza vaccination of patients
aged 65 years was associated with their physicians having favourable opinions about vacci-
nation. Therefore, the promotion of vaccination of primary care physicians by improving
their opinions and attitudes about influenza vaccination and taking into account scientific
evidence may have a beneficial effect on coverages in their patients. Some authors [37,38]
have pointed out that healthier persons are more likely to receive the vaccine than less-
healthy subjects (health vaccine bias) and if observational studies do not control adequately
Table 2. Results of multilevel regression for estimated of factors associated with influenza vaccine.
Model 1 (Enabling
resources) Adjusted
OR (95%CI)
p
value
Model 2 (Model 1
+ Predisposing characteristics)
Adjusted OR (95%CI)
p
value
Model 3 (Model 2 + Risk
medical conditions)
Adjusted OR (95%CI)
p
value
Enabling resources
Marital status
Married/Cohabiting 1 1 1
Single 0.55 (0.32–0.93) 0.03 0.55 (0.31–0.98) 0.04 0.56 (0.32–0.98) 0.04
Widowed 1.00 (0.72–1.38) 0.98 1.10 (0.77–1.58) 0.60 1.11 (0.77–1.59) 0.57
Separated/Divorced 0.72 (0.31–1.68) 0.45 0.87 (0.36–2.11) 0.76 0.85 (0.35–2.06) 0.72
No. of GP visits
0–2 1 1 1
3 1.72 (1.31–2.26) <0.001 1.57 (1.16–2.11) 0.003 1.61 (1.19–2.18) 0.002
Household size
Live alone 1 1 1
Lives with cohabitant 1.35 (0.91–2.01) 0.13 1.35 (0.88–2.07) 0.17 1.36 (0.89–2.09) 0.16
Barthel index
40 1 1 1
< 40 0.65 (0.44–0.97) 0.03 0.71 (0.46–1.08) 0.11 0.72 (0.47–1.09) 0.12
Predisposing
characteristics
Sex
Male 1 1
Female 0.77 (0.55–1.10) 0.14 0.76 (0.53–1.08) 0.12
Alcohol intake
No 1 1
Yes 0.48 (0.20–1.12) 0.09 0.49 (0.21–1.17) 0.11
Inﬂuenza vaccine in any
of the 3 previous seasons
No 1 1
Yes 13.07 (9.14–18.67) <0.001 13.57 (9.45–19.48) <0.001
23-valent pneumococcal
polysaccharide vaccine
No 1 1
Yes 1.95 (1.37–2.78) <0.001 1.97 (1.38–2.80) <0.001
Risk medical conditions
No 1
Yes 0.73 (0.47–1.14) 0.17
OR: odds ratio, GP: general practitioner
doi:10.1371/journal.pone.0147931.t002
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for those differences, the benefits of influenza vaccination might be exaggerated. One way to
avoid this kind of bias, could be the design of appropriately-powered RCTs [30,39]. However,
RCT are unacceptable among groups already advised to receive the vaccine annually [2] and
observational studies using bias-reducing methods likely represent the only possible option
to assess the effectiveness of the influenza vaccine in the elderly [40]. In a study carried out
during 10 seasons with no evidence of a healthy-vaccine bias, the effectiveness of the vaccine
against hospitalization was demonstrated [4]. A review of 75 studies in the elderly (only one
RCT, with the rest being cohort and case-control studies) concluded that the public health
safety profile of the vaccine appears to be acceptable, but the low quality of the available evi-
dence precluded clear conclusions being reached on the effects of the vaccine in the elderly
[41]. Osterholm et al. stated that evidence of protection for the present generation of influ-
enza vaccines in adults aged65 years is lacking and that new vaccines based on novel anti-
gens are needed; however the authors agreed that, in the meantime, public support for
present vaccines are the best intervention available for seasonal influenza and should be
maintained [42].
The World Health Organization (WHO), after considering that the available evidence sug-
gests that influenza vaccines are less effective in people aged65 years than in young adults,
states that vaccination is still the most efficacious public health tool for the protection of elderly
individuals against influenza and encourages its use in elderly persons because they have the
highest risk of mortality from the complications of influenza [43].
Advertising, provider and patient mailing, registry-based telephone calls and patient educa-
tion could also increase vaccination rates [44].
This study, like all observational studies has strengths and limitations. The main strength is
that the vaccination status was obtained from written documents (hospital medical records,
vaccination cards or primary healthcare registers) and, therefore, it is unlikely that this infor-
mation was biased. With the exception of two studies [20,30], in all the other studies cited
information on vaccination was obtained directly from the patient or physician. Another
strength is that only patients with unplanned hospital admission were included. These
patients enter for a variety of reasons and tend to be more representative of the general popu-
lation. A possible limitation might be that we excluded patients admitted to hospital for respi-
ratory disease, pneumonia or influenza-like illness. Patients hospitalized due to these diseases
had probably received the influenza vaccine less frequently than the overall population of
elderly people.
Another limitation is that other, unaccounted-for factors might explain some of the rela-
tionships observed. In the multilevel regression analysis we took into account several variables
that were not included in the final models. Therefore, the associations that were found in these
final models might be considered in future strategies to improve influenza vaccination cover-
ages in the elderly. Another possible limitation is that no standard definitions of predisposing
characteristics or enabling resources are available. We followed criteria similar to those used by
other authors [12–14] and, therefore the comparison may be considered valid. Finally, because
this is a cross-sectional study, no causal relationship can be established. However, the study
identified some variables that are associated with vaccination coverage in hospitalized patients
and could help improve vaccination strategies in the elderly.
In conclusion, the results of this study show that influenza vaccination coverages in elderly
hospitalized patients are low in Spain and should be increased. Some predisposing characteris-
tics were associated with a higher influenza vaccination coverage. Healthcare workers should
take these characteristics into account and be encouraged to proactively propose influenza vac-
cination to all patients aged65 years.
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